3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 1/2
2
Status
Recruiting
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Thoracic
1
Sarcoma
1
NET
1
Gynecologic
1
Genitourinary
1
Endocrine
1
Dermatologic
1
Conditions
Carcinoma, Non-Small-Cell Lung
125
Breast Neoplasms
82
Neoplasms
78
Colorectal Neoplasms
67
Neoplasm Metastasis
65
Prostatic Neoplasms
61
Leukemia, Myeloid, Acute
61
Ovarian Neoplasms
57
Recurrence
55
Pancreatic Neoplasms
55
Multiple Myeloma
52
Melanoma
40
Triple Negative Breast Neoplasms
36
Lung Neoplasms
36
Glioblastoma
36
Squamous Cell Carcinoma of Head and Neck
34
Endometrial Neoplasms
33
Lymphoma, Non-Hodgkin
32
Precursor Cell Lymphoblastic Leukemia-Lymphoma
30
Lymphoma, Large B-Cell, Diffuse
28
Carcinoma, Renal Cell
28
Lymphoma
27
Stomach Neoplasms
26
Small Cell Lung Carcinoma
26
Carcinoma, Hepatocellular
26
Myelodysplastic Syndromes
25
Lymphoma, B-Cell
25
Advanced Solid Tumor
25
Leukemia, Lymphocytic, Chronic, B-Cell
24
Brain Neoplasms
24
Interventions
olaparib
1
lutetium Lu 177 dotatate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1/2
×
Esthesioneuroblastoma, Olfactory
×
90 days
×
Clear all
NCT06607692
2026-06-04
LUPARPED
Fundación de investigación HM
Phase 1/2
Recruiting
25 enrolled
NCT06814496
2026-05-20
RABBIT
University of Arizona
Phase 1/2
Recruiting
30 enrolled